Delivery Order SPE2DB22D2211-SPE2DB24FPFG2

Award Date 8/26/24
Potential Completion Date 8/27/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $7,639.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFAZOLIN 2 G/50 ML-DEXTROSE medical supplies, which are critical pharmaceutical products used in military and government healthcare settings. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This federal contract award, valued at $1,187.46, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the supply of 4564677685 ! CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The award does not have...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,266.98 firm fixed price delivery order is for the supply of 4565582128 ! CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical antibiotic medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,228.56, is a delivery order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSE medical products. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,457.12 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,959.52 firm-fixed-price delivery order is for the supply of CEFAZOLIN 1 G/50 ML-DEXTROSES, a medical product, with an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of CEFAZOLIN 2 G/50 ML-DEXTROSES medical supplies. The contract has an award value of $1,032.45 and a completion date of July 29, 2024. It is a delivery order contract under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,537.95, is a Firm Fixed Price Delivery Order for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024 and was awarded on January 22, 2024. This award is part of a larger Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a firm fixed price Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract. The $1,445.28 award is for the supply of 4565734922 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical pharmaceutical product. The contract has a completion date of September 10, 2024 and does not utilize a set-aside designation. Amerisourcebergen, through its extensive supply...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,583.28 firm fixed-price delivery order is for the supply of CEFAZOLIN 2 G/50 ML-DEXTROSES, a medical product used in healthcare settings. The contract has an ultimate completion date of May 23, 2024 and is not designated as a set-aside award. Amerisourcebergen holds a significant $999,999,999 Indefinite...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FPFG2
    Delivery Order

This federal contract award, valued at $1,445.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4565584696 - CEFAZOLIN 2 G/50 ML-DEXTROSES, a critical medical product.

The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen to support military treatment programs and facilities worldwide.

The contract does not have a set-aside designation and is scheduled for completion by August 27, 2024. As a major supplier of essential medical commodities to the federal government, Amerisourcebergen's delivery of this critical pharmaceutical product will help meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 11/25/24, 9:03 AM